These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Practical experience with the detection Clostridium difficile]. Chmelarová E; Skapová T Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):86-9. PubMed ID: 20640985 [TBL] [Abstract][Full Text] [Related]
27. Dynamics of Clostridium difficile infection. Control using diet. Ward PB; Young GP Adv Exp Med Biol; 1997; 412():63-75. PubMed ID: 9191992 [TBL] [Abstract][Full Text] [Related]
28. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Viscidi R; Willey S; Bartlett JG Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125 [TBL] [Abstract][Full Text] [Related]
29. [Clostridium difficile:an epidemic event in service of public health]. Nau JY Rev Med Suisse; 2006 Sep; 2(78):2071. PubMed ID: 17019844 [No Abstract] [Full Text] [Related]
30. Molecular basis of early stages of Clostridium difficile infection: germination and colonization. Sarker MR; Paredes-Sabja D Future Microbiol; 2012 Aug; 7(8):933-43. PubMed ID: 22913353 [TBL] [Abstract][Full Text] [Related]
31. The role of toxin A and toxin B in the virulence of Clostridium difficile. Carter GP; Rood JI; Lyras D Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163 [TBL] [Abstract][Full Text] [Related]
32. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization. Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129 [TBL] [Abstract][Full Text] [Related]
33. Colonisation with digoxin-reducing strains of Eubacterium lentum and Clostridium difficile infection in nursing home patients. Bennett RG; Beamer BA; Greenough WB; Lindenbaum J; Bartlett JG J Diarrhoeal Dis Res; 1992 Jun; 10(2):87-92. PubMed ID: 1500644 [TBL] [Abstract][Full Text] [Related]
34. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Khanna S; Pardi DS Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014 [TBL] [Abstract][Full Text] [Related]
38. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136 [TBL] [Abstract][Full Text] [Related]
39. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Vindigni SM; Broussard EK; Surawicz CM Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153 [TBL] [Abstract][Full Text] [Related]
40. Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro. Diebel LN; Liberati DM J Am Coll Surg; 2014 Sep; 219(3):460-8. PubMed ID: 25067805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]